How to order the BIOTIA‑ID Urine Test
Getting started with Biotia is simple. Follow the steps below to register, place an order, send a patient sample, and review results — all through the Biotia Portal.
For recurrent, complicated, or culture-negative UTI patients
Prefer paper? Download important information and necessary forms here

Three steps from registration to results
- Step 01
Create your provider account and place a new order
Register for the Biotia Provider Portal using your NPI number and practice details, or let us do it for you. Log in to create a new order for your patient and select the BIOTIA-ID Urine NGS Assay.
- Step 02
Collect and ship the sample
Collect the urine specimen using the Biotia collection kit and ship it back using the prepaid overnight label included in the kit. Our laboratory will confirm receipt by email.
- Step 03
Review your results
Results are typically available within 3 business days of sample receipt. You will receive an email notification when your report is ready to view in the Provider Portal. Fax option is also available.
Need support? Biotia is here
We are here to help
Our clinical team is available to walk you through the ordering process, answer questions about test selection, and support you in interpreting results.
Biotia makes billing simple
The BIOTIA-ID Urine Test is not currently covered by insurance, but is HSA/FSA eligible. Invoices for diagnostic testing services will be sent to either the clinic or the patient, depending on the information included on the test requisition. For questions pertaining to billing, you may reach out to billing@biotia.io.
Order test kits for your clinic
Biotia will send test kits to clinicians interested in offering the test kit at their practice location(s) with prepaid, overnight shipping labels included. To receive test kits at your clinic, reach out to clinicalsupport@biotia.io.
Frequently Asked Questions
Instructions and materials
Disclaimer
NYS LDT Approved Diagnostic Test
The BIOTIA-ID Urine NGS Assay has been approved by New York State Department of Health's Clinical Laboratory Evaluation Program as an in vitro diagnostic laboratory developed test (LDT). This assay was developed and its performance characteristics determined by Biotia. The assay has not been cleared or approved by the FDA, nor is it required to be. The Biotia Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) and is accredited to perform high-complexity clinical laboratory testing.
